VT-111 comments

Dr TNews for Professionals, Professionals Leave a Comment

LONDON, Dec. 16, 2010: In a press release by Viron Therapeutics about the protective effects of VT-111 during stenting, the CEO of the company announced: “Although the use of cardiovascular stents have dramatically improved the outcomes for patients with occlusive coronary artery disease, numerous studies have shown that the procedure itself can cause what is termed peri-procedural myocardial injury (PMI),” …

Severe Chestpains and fainting

Dr TAsk Doctor T Leave a Comment

Q: I am a 51 year old woman who is fit and healthy, low cholesterol, low fat diet, no food before bedtime, low to average BP and pulse. Grandfather died of heart attack at 53 the other at 73, father died early of trauma, grandmothers died of heart disease in 80s & 90s. Have Raynauds, GORD nexium 40mg daily. long …

Severe Chestpains and fainting

Dr. TAsk Doctor T Leave a Comment

Q: I am a 51 year old woman who is fit and healthy, low cholesterol, low fat diet, no food before bedtime, low to average BP and pulse. Grandfather died of heart attack at 53 the other at 73, father died early of trauma, grandmothers died of heart disease in 80s & 90s. Have Raynauds, GORD nexium 40mg daily. long …

Heart rate during exercise

Dr. TAsk Doctor T Leave a Comment

Q: Hi, when I exercise my heart goes faster but it doesnt get much harder, I have recently noticed this, I am on a beta blocker 75 mg a day. I am not fat, but I havent really been active in 6 months. Its feels like my heart needs to beat harder, but it just stays fast.Could this be because …

How many PACs or PVCs are too many

Dr. TAsk Doctor T 8 Comments

Follow-up question: Dr T, I thank you for your time and greatly appreciate the advice.  Reading back through my initial correspondence I believe it would be better to say that when I exercise I seem to notice 3 or 4 premature beats at separate times, not coming at once.  I do not believe they are more prevalent during exercise, just …

VT-111 results

Dr TNews for Professionals, Professionals Leave a Comment

Viron phase 2a data, published in leading cardiovascular journal, circulation: cardiovascular interventions. VT-111 results demonstrate statistically significant reduction in two key biomarkers of cardiac damage.  LONDON, ON, Dec. 16 /PRNewswire/ – Viron Therapeutics Inc. today announced that the results of Viron’s Phase 2a trial for VT-111 were published today in Circulation: Cardiovascular Interventions. In the study led by Dr. Jean-Claude Tardif, …